SMS Reminders to Improve Medication Adherence of Aromatase Inhibitors
NCT02524548 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 244
Last updated 2020-06-29
Summary
The purpose of this study is to determine whether weekly SMS reminders are effective in improving medication adherence of adjuvant aromatase inhibitors in women with breast cancer.
Conditions
- Breast Cancer
- Medication Adherence
Interventions
- OTHER
-
SMS reminder
Weekly SMS reminder to take aromatase inhibitors as prescribed by doctor for 1 year
Sponsors & Collaborators
-
Singapore Cancer Society
collaborator OTHER -
National University of Singapore
lead OTHER
Principal Investigators
-
Bee Choo Tai, PhD · National University of Singapore
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Max Age
- 80 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-05-31
- Primary Completion
- 2019-12-31
- Completion
- 2020-01-31
Countries
- Singapore
Study Locations
More Related Trials
-
Interactive Care Plan for the Monitoring of Symptoms and Recovery in Patients With Stage 0-III Breast Cancer
NCT04693338 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer
NCT02246621 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Motivational Enhancement Therapy to Improve Adherence to Aromatase Inhibitors
NCT02883361 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Writing Interventions in Breast Cancer Patients Taking Aromatase Inhibitors
NCT04651452 ·Status: COMPLETED ·Phase: NA
-
Impact of Web Application Support Versus Standard Management on Compliance With Adjuvant Hormone Therapy at 18 Months in Patients Treated for Breast Cancer
NCT04554927 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Phase 1/2 Study of Amcenestrant (SAR439859) Single Agent and in Combination With Other Anti-cancer Therapies in Postmenopausal Women With Estrogen Receptor Positive Advanced Breast Cancer
NCT03284957 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Non-interventional Study to Evaluate Arimidex in Postmenopausal Women With Advanced Breast Cancer
NCT00562458 ·Status: COMPLETED
-
Adherence of Hispanic / Latina Breast Cancer - Patients to Adjuvant Aromatase Inhibitors
NCT03144037 ·Status: COMPLETED
-
Joint Pain and Medication Adherence in Postmenopausal Women Receiving Aromatase Inhibitors
NCT00954564 ·Status: COMPLETED
-
Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk
NCT04570956 ·Status: TERMINATED ·Phase: PHASE2
-
Compliance to a Hormone Therapy Regimen in Breast Cancer
NCT00666822 ·Status: COMPLETED
-
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
NCT00516698 ·Status: COMPLETED
-
Analysis of Initial Adherence and Its Impact on Long-term Adherence to Hormonal Therapy for Breast Cancer
NCT03186599 ·Status: UNKNOWN ·Phase: NA
-
Adherence to Aromatase Inhibitors: The Role of Partners
NCT02753985 ·Status: COMPLETED
-
An Innovative Smartphone Application for Adverse Event Management During Breast Cancer Adjuvant Chemotherapy
NCT05258461 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.
NCT00287534 ·Status: COMPLETED ·Phase: PHASE2
-
Adherence Improving Self-Management Strategy (AIMS) in Breast Cancer Patients Using Adjuvant Endocrine Treatment (AET)
NCT04719455 ·Status: UNKNOWN ·Phase: NA
-
Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer
NCT02598557 ·Status: COMPLETED ·Phase: PHASE2
-
Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast Density
NCT00238316 ·Status: COMPLETED ·Phase: PHASE2
-
Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
NCT00382070 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast Cancer
NCT02400060 ·Status: COMPLETED ·Phase: NA
-
Increasing Oral Medication Adherence for Metastatic Breast Cancer Patients
NCT06726889 ·Status: RECRUITING
-
Trial of Chidamide in Combination With Exemestane in Patients With Advanced Breast Cancer
NCT02482753 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Amcenestrant (SAR439859) Versus Tamoxifen for Patients With Hormone Receptor-positive (HR+) Early Breast Cancer, Who Have Discontinued Adjuvant Aromatase Inhibitor Therapy Due to Treatment-related Toxicity
NCT05128773 ·Status: TERMINATED ·Phase: PHASE3
-
Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy Adherence
NCT04054557 ·Status: COMPLETED ·Phase: NA